The 11th Annual Pharma Anti-Counterfeiting & Serialisation 2023 was a pivotal event held on 7-8 February 2023 at the Pestana Chelsea Bridge Hotel in London, UK. Organised by Virtue Insight, this conference focused on combating the global issue of counterfeit pharmaceuticals through advanced serialisation and anti-counterfeiting strategies. It brought together industry leaders, regulatory authorities, and experts to discuss and develop solutions to safeguard the pharmaceutical supply chain.
Key topics covered included the latest advancements in serialisation technologies, track and trace systems, and the implementation of blockchain for enhanced supply chain integrity. Sessions delved into regulatory compliance, particularly concerning the Drug Supply Chain Security Act (DSCSA) and the European Falsified Medicines Directive (FMD), providing insights into global standards and best practices. The conference also addressed the economic and health impacts of counterfeit drugs, emphasizing the need for robust security measures to protect patients and preserve brand integrity.
The event featured a series of keynote presentations and panel discussions from distinguished speakers such as Luis Perez, Country Attache for the UK at the FDA Office of Criminal Investigations; Thomas Welch, Deputy Attache at the London Office of the Department of Homeland Security; and Heather Henson, Senior Director of Investigations and Intelligence at Genentech. Networking opportunities were abundant, allowing attendees to engage with leading international vendors and explore innovative solutions in the co-located exhibition. The conference aimed to foster collaboration and knowledge sharing among stakeholders to strengthen the pharmaceutical industry's response to counterfeiting.
This conference was particularly beneficial for pharmaceutical manufacturers, distributors, regulatory agencies, and technology providers involved in supply chain security. It offered a platform to stay abreast of emerging trends, share experiences, and collaborate on effective strategies to combat counterfeit medicines, thereby ensuring patient safety and maintaining the integrity of the pharmaceutical market.
Speakers(18)
Alexandru Popa
Associate Director, Blockchain for Pharma Supply Chain at MSD
Alexandru Popa serves as Associate Director for Blockchain in Pharma Supply Chain at MSD, implementing blockchain solutions to enhance supply chain transparency.
Duccio Lombardi
Serialization Normatives Compliance & Anti-Counterfeiting Corporate Quality Unit Head at Menarini
Duccio Lombardi heads the Corporate Quality Unit at Menarini, focusing on serialization compliance and anti-counterfeiting measures.
Grant Courtney
Founder and CEO at Smarter and Safer Products
Grant Courtney is the Founder and CEO of Smarter and Safer Products, a company dedicated to developing innovative safety solutions.
Gustavo Morais
Partner, Member of Managing Committee at Dannemann Siemsen
Gustavo Morais is a Partner and member of the Managing Committee at Dannemann Siemsen, a law firm specializing in intellectual property.
Heather Henson
Senior Director, Investigations and Intelligence at Genentech (USA)
Heather Henson leads Investigations and Intelligence at Genentech, focusing on safeguarding the company's assets and information.
Heiko Trefzger
Senior Business Analyst & Product Manager at Roche
Heiko Trefzger is a Senior Business Analyst and Product Manager at Roche, specializing in product development and market analysis.
Hugues Isel
Global Quality Manager - Crisis Management at Roche
Hugues Isel manages global quality and crisis management at Roche, overseeing quality assurance and crisis response strategies.
Jose H. Werner
Partner at Dannemann Siemsen
Jose H. Werner is a Partner at Dannemann Siemsen, focusing on intellectual property law.
Jyrki Syvaeri
Corporate Director Supply Chain Integrity at Boehringer Ingelheim
Jyrki Syvaeri is the Corporate Director of Supply Chain Integrity at Boehringer Ingelheim, ensuring the security and compliance of the company's supply chain.
Kasper Ernest
Secretary General at Affordable Medicines Europe
Kasper Ernest serves as Secretary General of Affordable Medicines Europe, advocating for access to affordable medicines.
Leyla Hannbeck
CEO at National Pharmacy Association (NPA)
Leyla Hannbeck is the Chief Executive Officer of the National Pharmacy Association, representing community pharmacies.
Luis Perez
Country Attache for UK at FDA Office of Criminal Investigations
Luis Perez serves as the Country Attache for the United Kingdom at the FDA Office of Criminal Investigations, overseeing enforcement and investigative operations.
Mike Isles
Executive Director at European Alliance for Access to Safe Medicines
Mike Isles is the Executive Director of the European Alliance for Access to Safe Medicines, promoting safe and effective medicines.
Mohamed Ibrahim
Section Head – Regulatory Affairs at Batterjee Pharma (Saudi Arabia)
Mohamed Ibrahim leads Regulatory Affairs at Batterjee Pharma in Saudi Arabia, ensuring compliance with pharmaceutical regulations.
Monika Derecque-Pois
Director General at GIRP — European Healthcare Distribution Association
Monika Derecque-Pois is the Director General of GIRP, representing European healthcare distributors.
Neha Mehta
Regulatory CMC Facilitator at Novartis
Neha Mehta facilitates Regulatory Chemistry, Manufacturing, and Controls at Novartis, ensuring regulatory compliance in product development.
Sonia Queiros
COO at European Medicines Verification Organisation (EMVO)
Sonia Queiros is the Chief Operating Officer of the European Medicines Verification Organisation, overseeing operations to ensure medicine authenticity.
Thomas Welch
Deputy Attache at London Office, Department of Homeland Security
Thomas Welch is the Deputy Attache at the London Office of the Department of Homeland Security, coordinating international security efforts.
Event Details
- Date
- February 7-8, 2023
- 2 days
- Location
- 🇬🇧 London, United Kingdom
- Pestana Chelsea Bridge Hotel
- Pricing
- £899 - £1,299 + VAT
- Audience
- Pharmaceutical manufacturers, distributors, regulatory agencies, technology providers
- Attendees
- Not specified